what are the upcoming near term announcements that may act as price catalysts?
I have the following on my radar:
ph3 trial commencement (mid year -> to me means sometime in June/July) - not sure this will cause too much excitement.
additional indications - vague on when this may occur - seems wide open to me.
BTD 60 days from fda meet in april - so if its going to be granted needs to be soon. flipper seemed very confident, no reasoning why so seems highly speculative.
acadia q2 numbers ->early august (aug7th last year)
canada daybue pricing review ->was it 60 days, so sometime in July?
hie, pths, as fda meets all in q4.
Other??
So quite possibly unless something speculative or surprising comes out, which of course it might, quiet on the potential price rerating catalysts until daybue numbers in august.
Have I missed anything or have anything wrong?
NEU Price at posting:
$13.90 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)